• Facebook
  • X
  • Instagram

Advocating for the Australian MPN Community

MPN Alliance Australia
  • Home
  • About Us
    • Mission & Logo
    • Our Team
    • Our History
    • MPN AA fund
    • Our Partners
  • Understanding MPN
    • What are MPNs
    • Newly diagnosed
    • MPN guidelines and articles
      • Essential thrombocythemia
      • Polycythemia vera
      • Myelofibrosis
      • Genetics information
    • Treatments
      • Anagrelide (Agrylin)
      • Aspirin
      • Busulfan
      • Hydroxycarbamide (hydroxyurea)
      • Interferon Alpha (Pegasys)
      • Fedratinib (Inrebic)
      • Momelotinib (OMJJARA)
      • Ruxolitinib (Jakavi)
      • Stem cell transplants
      • Venesection (phlebotomy)
      • Articles on MPN treatment
    • MPN symptoms
    • FAQs
  • Resources
    • Young people with MPNs
    • Haematology appointments
    • Wallet Cards & Brochures
    • MPN conferences and patient education events
      • MPN Education symposium Perth, October 2025
      • Patient information event, Sydney, February 2019
      • 2017 MPN patient program, Melbourne
    • Australian clinical trials
    • Australian and international support
    • MPN Matters Newsletters
    • COVID-19 resources for MPN patients
  • Living Well
    • Healthy Eating
    • Cardiovascular health
    • Recognising and preventing blood clots
    • Benefits of exercise for MPN patients
    • Keeping muscles strong to stay well with MPN
    • Meditation
  • Patient Stories
    • Sarah’s story
    • Linda’s story
    • Frank’s story
    • Charlie’s story
    • Libby’s story
    • Tereena’s story
    • Sharon’s story
    • Chris’ story
    • Doreen’s story
    • Heather’s story
    • Jennie’s story
    • Kathy’s story
    • Matthew’s story
    • Nathalie’s story
    • Tracy’s story
    • Sam’s story
    • Ken’s story
    • Jenny’s story
  • Events
  • News
  • Contact
  • Search
  • Menu Menu

Archive for category: Survey

You are here: Home1 / News2 / Survey

Myelofibrosis: management of stem cell transplants in Europe

January 21, 2026/in News, Patient Education, Survey/by Jenny
Read more
Share to:
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/favicon-mpn-aa.png 430 430 Jenny https://www.mpnallianceaustralia.org.au/wp-content/uploads/2019/01/MPNAA_logo_og_image_1200_630-e1643087758121-1030x391.jpg Jenny2026-01-21 23:05:522026-01-29 21:17:11Myelofibrosis: management of stem cell transplants in Europe

Latest news

  • Study on how some MPNs transform to AMLMay 11, 2026
  • Clonal hematopoiesis: insights into risk, biology, and therapeutic strategies.May 10, 2026
  • Risk factors of secondary malignancies in PVMay 1, 2026
  • Challenges diagnosing MPNs with low JAK2V617F allelic burdenApril 26, 2026
  • How MPNs evolve on therapyApril 23, 2026
  • Paradigm shift in PV treatment?April 15, 2026

Yearly archives

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

The MPN Alliance Australia works in partnership with the Leukaemia Foundation

MPN Alliance Australia Newsletter

MPN clinical trials recruiting in Australia

The MPN AA has put together a list of clinical trials that we believe are recruiting in Australia at the moment. See our document on our Clinical trials page  
© Copyright 2026 MPN Alliance Australia
  • Disclaimer
  • Privacy Policy
Scroll to top
Translate »